@article{ref1,
title="Erratum to: The potential utility of tildrakizumab: an interleukin-23 inhibitor for the treatment of psoriasis (Expert Opinion on Investigational Drugs, (2017), 26, 2, (243-249), 10.1080/13543784.2017.1274734)",
journal="Health (London)",
year="2022",
author="",
volume="26",
number="2",
pages="e263-e263",
abstract="Due to an administrative error, an incomplete list of Guest Editors was published in Print for the special issue: Critical Suicide Studies Special Edition: Between Methodology and Ethics. The Guest Editors of this special issue are Amy Chandler, Rob Cover and Scott J Fitzpatrick. The online page of the special issue has been corrected. © The Author(s) 2022.<p /><p>Language: en</p>",
language="en",
issn="1363-4593",
doi="10.1177/13634593221076602",
url="http://dx.doi.org/10.1177/13634593221076602"
}